Suppr超能文献

维生素C能否预防创伤和骨科护理中的Ⅰ型复杂性区域疼痛综合征?文献及当前研究结果的系统评价

Vitamin C Could Prevent Complex Regional Pain Syndrome Type I in Trauma and Orthopedic Care? A Systematic Review of the Literature and Current Findings.

作者信息

Giustra Fortunato, Bosco Francesco, Aprato Alessandro, Artiaco Stefano, Bistolfi Alessandro, Masse Alessandro

机构信息

Department of Orthopedics and Traumatology, University of Turin, Turin, Italy.

出版信息

Sisli Etfal Hastan Tip Bul. 2021 Jul 2;55(2):139-145. doi: 10.14744/SEMB.2021.82335. eCollection 2021.

Abstract

The aim of this systematic review is to evaluate the efficacy of Vitamin C (VC) in preventing Complex Regional Pain Syndrome type I (CRPS-I) in fractures or surgery of the upper and lower extremities. During December 2020, Scopus and PubMed search was performed to analyze VC supplementation in preventing CRPS-I after trauma and orthopedic care, according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses guideline. Patient, Intervention, Comparison, Outcomes, Study Design model, and a modified version of the Coleman Methodology Score were used to analyze the included studies. The research was limited from 1990 to December 2020. Initial screening results identified 649 studies. After reviewing each study, six clinical studies were included in the study. A total of 2026 patients of whom 632 male and 1394 female were collected in our systematic review. During the entire follow-up period, the occurrence of CRPS-I was evaluated in 1939 patients. Five of the six analyzed studies were favoring prophylactic use of the 500-1000 mg daily dose of VC for 45-50 days after orthopedic or trauma care for prevention of CRPS-I. Only one study found no benefit in VC supplementation compared with placebo to prevent CRPS-I. Analysis of the literature suggests that a daily 500-1000 mg VC supplementation may reduce the onset of CRPS-I in trauma of upper/lower extremities and in orthopedic surgery.

摘要

本系统评价的目的是评估维生素C(VC)在预防上肢和下肢骨折或手术后复杂性区域疼痛综合征I型(CRPS-I)方面的疗效。2020年12月,根据系统评价和Meta分析的首选报告项目指南,在Scopus和PubMed数据库进行检索,以分析补充VC预防创伤和骨科治疗后CRPS-I的情况。采用患者、干预措施、对照、结局、研究设计模型以及Coleman方法评分的修改版对纳入研究进行分析。研究限定在1990年至2020年12月期间。初步筛选结果确定了649项研究。在对每项研究进行评估后,6项临床研究被纳入本研究。在我们的系统评价中,共收集了2026例患者,其中男性632例,女性1394例。在整个随访期间,对1939例患者评估了CRPS-I的发生情况。6项分析研究中的5项支持在骨科或创伤治疗后预防性使用每日500-1000mg VC,持续45-50天以预防CRPS-I。只有1项研究发现补充VC与安慰剂相比在预防CRPS-I方面无益处。文献分析表明,每日补充500-1000mg VC可能会降低上肢/下肢创伤及骨科手术中CRPS-I的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e682/8298085/acdd32abf5ed/MBSEH-55-139-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验